In Depth 9 May 2024
BTK inhibitors: can these drugs tackle cancer and autoimmunity?
…treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases. One of the drugs shooting for the crown is Sanofi’s rilzabrutinib. The…